Radio Waves, Real Results: Inside NeuroEM’s Alzheimer’s Moonshot

We’re taking a short break while we work on our new season, but in the meantime, we’ve got a special encore episode from our archives where we chat with a powerful force in the fight against Alzheimer’s disease: Meryl Comer, a member of our Alzheimer’s Moonshot Impact Board. Driven by personal experience watching her husband battle the disease, Comer transformed from award-winning journalist to passionate advocate. She is the Co-founder & Board Member of UsAgainstAlzheimers; the U.S. Representative for the Global Brain Trust; and Vice-Chair of WHAM (Women’s Health Access Matters). Hear her story: Witnessing the devastating effects of Alzheimer’s firsthand Taking action through co-founding UsAgainstAlzheimers The critical role of advocacy and policy change The emotional and physical burden of caregiving Comer also shares her insights on: Destigmatizing Alzheimer’s diagnosis Anchoring innovation in the realities of care Treating the source of the disease This episode is a must-listen for anyone affected by Alzheimer’s, passionate about healthcare innovation, or inspired by the power of advocacy. Stay tuned, and we'll be back soon with more fresh content!   Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

The phrase "Food as Medicine" has moved beyond buzzwords to become a powerful force in health tech and digital health. From dedicated pavilions at major conferences like HLTH to a growing understanding of its profound impact to StartUp Health's newly-launched Food as Medicine Health Moonshot Community, the concept is clear: what we eat plays a crucial role in preventing and managing chronic diseases – often more so than medication alone. Nutrition is not just about sustenance or weight management; it's a vital tool in fighting disease and fostering overall wellbeing. Beyond its direct health benefits, treating food as medicine offers a unique advantage: it connects us. Sharing meals builds community and belonging, essential elements for human health and thriving that a pill simply cannot replicate. In this episode, we speak with Rich Bennett, CEO & Co-founder of Epicured, a true standard-bearer in the Food as Medicine movement. Epicured delivers medically-tailored meals directly to individuals' homes, offering personalized nutrition plans designed by a team of expert nutritionists and Michelin-starred chefs, catering to a range of health conditions. We delve into Epicured's exciting recent developments, including their groundbreaking partnership with Medicaid in New York State. This significant move expands access to their life-changing service to a wider population, particularly those who may not have had the means to benefit previously. Bennett also shares his insights on joining as a founding member of StartUp Health's Food as Medicine Health Moonshot Community, highlighting the collaborative efforts driving innovation and growth in this vital field. Epicured is one of the exciting growth stories in digital health today, and they are at a fascinating inflection point. Join us as Bennett discusses their recent successful fundraise and their ambitious plans to scale up production at their "healing food" facilities. This is a pivotal moment for Epicured and the entire Food as Medicine movement. Tune in to hear how they are revolutionizing healthcare, one delicious and nutritious meal at a time. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

In this episode of StartUp Health NOW, we dive into one of the most fascinating innovation stories in health tech. Our guest is Chuck Papageorgiou, CEO of NeuroEM Therapeutics, a company that’s part of StartUp Health’s Alzheimer’s Moonshot Community and is making waves with a radically different approach to treating Alzheimer’s disease — using radio waves. What started as a research study to prove that cell phones cause brain cancer led to an unexpected breakthrough: the very same radio frequencies used in phones appeared to improve brain health in mice with Alzheimer’s. The discovery sparked a scientific journey that has since included promising human trials, FDA Breakthrough Device designation, partnerships, and progress towards bringing this non-invasive, affordable, at-home therapy to millions. Papageorgiou shares how NeuroEM’s wearable headset is helping untangle the brain’s toxic proteins, the science behind this counterintuitive tech, and why the impact could rival — or even surpass — that of current Alzheimer’s drugs. If you're looking for an inspiring story about accidental genius ideas, bold leadership, and breakthrough innovation in brain health, this one’s a must-listen. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

AI has been quietly transforming healthcare for years, but the arrival of ChatGPT changed the game. Suddenly, everyone—from patients to investors—could see the real-world impact of AI in making healthcare more efficient and accessible. One company leading this transformation is Mediktor, a pioneer in AI-powered symptom assessment. Before AI had its cultural moment, Mediktor—a member of the StartUp Health community since 2016—was already using it to help stratify patients and guide them to the right level of care. Now, they’re growing rapidly and shaping the future of AI in healthcare. In this episode, we chat with Cristian Pascual, CEO & Co-founder of Mediktor, to discuss: The evolution of AI in healthcare and why it’s accelerating now How Mediktor’s AI-driven symptom assessment is improving patient care The challenges of AI in healthcare, including LLMs, "black-box" models, and hallucinations Why a hybrid AI approach—combining automation with human safeguards—is the future As AI continues to shape healthcare, companies must balance innovation with accuracy. Pascual shares insights on how to harness AI’s power while ensuring reliability and trust. Tune in to explore the next wave of AI in healthcare—and what it means for patients, providers, and the industry at large. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

We all know light therapy can brighten our mood, especially for those battling depression or seasonal affective disorder. But what if light could do so much more? In this week's episode of StartUp Health NOW, we dive deep into the revolutionary work of StartUp Health community member Mai Nguyen, PhD, CEO & Co-founder of Optoceutics. Forget what you think you know about light therapy. Nguyen and her team are pioneering a new frontier, demonstrating how precisely delivered light, through the eyes, can actually reprogram brain waves. This isn't just about mood enhancement; it's about potentially slowing the progression of neurodegenerative diseases like Alzheimer's. Join us for a fascinating conversation with Nguyen, a Berkeley researcher turned entrepreneur, as she discusses her groundbreaking device, currently marketed as a wellness tool, but with profound clinical aspirations. Discover how her collaboration with engineers in Copenhagen has led to a novel technology that's already making waves. This episode will challenge your perception of the lights around you and illuminate the future of brain health. Get ready to have your mind blown! Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Imagine this: 73 million Americans are over 65. Among them, 10-20% experience mild cognitive impairment (MCI), a potential precursor to Alzheimer’s. Yet their primary care doctors, with only 14 minutes per patient, lack the time for crucial neurological screenings. This is a critical gap in our healthcare system, especially as groundbreaking Alzheimer's research and therapies emerge, making early detection more vital than ever. That’s where Cx Precision Medicine comes in. In this episode, we sit down with Sid O’Bryant, PhD, and Danguole Altman, the team behind CxPM, a company in the StartUp Health Alzheimer's Moonshot Community working to revolutionize early cognitive screening with a simple blood test. Their innovative diagnostic tool is designed to detect neurodegenerative diseases earlier, ensuring patients get the right care at the right time. O’Bryant's extensive research, now commercialized by Altman's leadership, offers a powerful tool for personalized care, enabling earlier, more accurate diagnoses of neurodegenerative diseases. We'll dive into their unique journeys, the science behind their innovative blood test, and how it's poised to transform patient care.    Discover how Cx Precision Medicine is empowering patients to get the right care at the right time, streamlining the diagnostic process and ultimately, improving lives. Join us as we explore the future of Alzheimer's detection and the hope it brings. Let's get into it! Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

On this episode of StartUp Health NOW, we learn about the power of photobiomodulation, a light therapy that promotes healing at the cellular level. From treating seasonal affective disorder to wound healing, light therapy's applications are expanding. We're joined by Guillaume Blivet of REGEnLIFE, a member of the StartUp Health community who is pioneering research into using photobiomodulation to address Alzheimer's disease. Learn how their unique approach, targeting both the brain and gut, shows promise in reducing inflammation and improving cellular health. We discuss the science, the promising early results, and the potential of this groundbreaking approach. Unveiling Photobiomodulation: Dive into the science of photobiomodulation, a cutting-edge light therapy that stimulates cellular healing at the molecular level. Explore how specific wavelengths of red and near-infrared light can trigger biological responses, reducing inflammation and promoting cellular health. Beyond Traditional Light Therapy: Discover how researchers are pushing the boundaries of light therapy beyond seasonal affective disorder and dermatology. Learn about innovative applications of photobiomodulation for internal therapeutic benefits. REGEnLIFE's Revolutionary Approach: Meet Guillaume Blivet, co-founder of REGEnLIFE, and his team's pioneering work in applying photobiomodulation to combat Alzheimer's disease. Explore their unique strategy of targeting both the brain and the gut simultaneously, leveraging the crucial gut-brain connection. Learn about the animal studies that have shown promising results. Innovation in Alzheimer's Treatment: Understand how REGEnLIFE's photobiomodulation therapy aims to slow the progression of Alzheimer's by reducing neuroinflammation and enhancing cellular function. Hear about the ongoing human trials in France and the potential for this non-invasive, safe treatment to transform Alzheimer's care. Tune in now as we learn how targeting the gut-brain connection with specific wavelengths of light could offer new hope for patients.   Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

When your health is on the line, accurate diagnostics are crucial. But many blood tests suffer from false positives, false negatives, and frustrating gray areas. In this episode of StartUp Health NOW, host Logan Plaster sits down with John Forrest, CEO & Co-founder of Veravas, a member of the StartUp Health community, to discuss their groundbreaking solution. VeraBIND: Learn how Veravas' patented technology cleans blood samples to remove impurities, dramatically increasing diagnostic accuracy and eliminating ambiguous results. Transforming Alzheimer's Detection: Find out how VeraBIND results in a test with a single result that says yes, you have the disease, or no, you don’t. Beyond Blood: Explore the potential of VeraBIND to transform diagnostics for a wide range of diseases, even using saliva samples – which are much easier for older patients to manage on a regular basis. The Future: Hear Forrest's insights on the challenges and opportunities in the health tech industry and how Veravas is poised to make a significant impact. Tune in for the conversation and learn how Veravas is turning the tide on diagnostic uncertainty.   Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Are health tech founders building what the market actually needs? At StartUp Health, we see firsthand their biggest challenge: achieving product-market fit. But it's more than just market alignment. Investor Robert Garber of 7wireVentures calls it "contract-market fit"—proof that people will pay. This week, we talk with Robin Roberts, CEO & Founder of DatosX, a company in the StartUp Health community that is helping digital health startups achieve just that. The Problem: Many early-stage health companies struggle with product-market fit. They may be building amazing technology, but the market isn't ready. The Solution: DatosX is a two-sided marketplace connecting health tech buyers (like hospitals) with startups. This enables: Pre-validation of purchases by hospitals. Creation of buyable products by startups. The Insight: This unique position gives Roberts a front-row seat to what hospitals really want (hint: it involves physician efficiency) and where startups often miss the mark. The Opportunity: We explore these critical trends and discover the opportunities for savvy startups in 2025. Listen in as Roberts shares his insights on achieving product-market fit and contract-market fit in the digital health space. The Access to Care Moonshot Community is comprised of mission-aligned founders and CEOs collaborating to accelerate breakthroughs to deliver quality care to everyone, regardless of location or income. » Meet the Access to Care Moonshot Community » Join a Health Moonshot Community Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

Ever wonder where the next big breakthrough in health will come from? Sometimes, the most innovative solutions arise from the most unexpected places. This week’s podcast episode dives into the fascinating world of a neurosurgeon who's revolutionizing glucose monitoring. Join us as we explore the groundbreaking work of Dr. Casey Halpern, co-founder of SynchNeuro, who is changing cardiometabolic care via the brain. We discuss: The unexpected connection between the brain and metabolism: How a neurosurgeon specializing in Parkinson's disease came across a game-changing approach to glucose monitoring. A non-invasive CGM for everyone: Learn about SynchNeuro's innovative behind-the-ear EEG device that could make continuous glucose monitoring accessible and affordable for millions at risk of Type 2 diabetes and heart disease. From physician to founder: Dr. Halpern shares his inspiring story as a doctorpreneur, leading the double life of a medical career and leading a cutting-edge health tech startup. The future of cardiometabolic health: We explore how this new technology, combined with the rise of GLP-1 medications, could transform the way we manage and prevent diabetes and heart disease. The science behind the breakthrough: A deep dive into the research connecting brain signals to appetite and blood sugar regulation. Tune in to discover how SynchNeuro – a member of our Cardiometabolic Health Moonshot Community – is poised to reshape the landscape of cardiometabolic health and empower individuals to take control of their wellbeing.   For years, chronic health problems like heart disease and Type 2 diabetes have grown, becoming some of society's biggest killers. Thankfully, there's a generation of entrepreneurs tackling the issue from every angle. In the Cardiometabolic Health Moonshot Community, mission-aligned founders and CEOs collaborate to accelerate breakthroughs in cardiometabolic disease prevention, diagnosis, monitoring, management, and cures. » Meet the Community » Join the Community Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot Community Showcase Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.